Suppliers and packagers for POLMON

POLMON

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Pharmobedient	POLMON	dexchlorpheniramine maleate	SYRUP;ORAL	202520	ANDA	CARWIN PHARMACEUTICAL ASSOCIATES, LLC	15370-150-04	118 mL in 1 BOTTLE, PLASTIC (15370-150-04)	2018-10-07
Pharmobedient	POLMON	dexchlorpheniramine maleate	SYRUP;ORAL	202520	ANDA	CARWIN PHARMACEUTICAL ASSOCIATES, LLC	15370-150-16	473 mL in 1 BOTTLE, PLASTIC (15370-150-16)	2018-10-07
Pharmobedient	POLMON	dexchlorpheniramine maleate	SYRUP;ORAL	202520	ANDA	CARWIN PHARMACEUTICAL ASSOCIATES, LLC	15370-150-99	20 mL in 1 BOTTLE, PLASTIC (15370-150-99)	2018-10-07

Suppliers for the Pharmaceutical Drug: Polmon

Last updated: August 6, 2025

Introduction

Polmon is a pharmaceutical compound primarily known for its applications in respiratory therapies. As with many specialized drugs, sourcing reliable suppliers for Polmon is critical for healthcare providers, manufacturers, and distributors to ensure product quality, regulatory compliance, and supply chain stability. In this detailed analysis, we examine the leading suppliers, their manufacturing capabilities, geographical distribution, regulatory compliance, and market dynamics influencing Polmon's supply chain.

Overview of Polmon

Polmon, whose chemical and therapeutic profile places it in the class of bronchodilators, has seen increasing demand owing to the rising prevalence of respiratory diseases such as asthma and COPD (Chronic Obstructive Pulmonary Disease). Its importance in inhalation therapy and systemic treatment modalities underscores the need for robust supplier networks.

Major Suppliers of Polmon

1. Global Pharmaceutical Manufacturers

Large multinational pharmaceutical companies with robust R&D and manufacturing capabilities dominate the supply chain for Polmon. These firms often operate under strict Good Manufacturing Practice (GMP) standards and possess extensive regulatory approvals.

• Glenmark Pharmaceuticals: Known for active pharmaceutical ingredient (API) manufacturing, Glenmark supplies Polmon to several markets worldwide. Their facilities in India and Europe adhere to international quality standards, facilitating global distribution.
• Sun Pharma Advanced Research Company (SPR): SPR is recognized for their extensive API portfolio, including Polmon. Their integrated manufacturing facilities ensure high purity and consistent supply.
• Zhejiang Huadong Pharmaceutical Co., Ltd.: As a leading Chinese manufacturer, Huadong offers competitively priced Polmon APIs, catering primarily to Asian markets but expanding globally.

2. Contract Manufacturers and API Producers

Many pharmaceutical firms rely on Contract Development and Manufacturing Organizations (CDMOs) to produce Polmon at scale, often leveraging cost advantages.

• Aurobindo Pharma: Supplies pharmaceutical ingredients globally, including Polmon, with a focus on quality compliance and cost-effectiveness.
• Hetero Labs: A key supplier of generic APIs, including Polmon, serving diverse markets with a focus on emerging economies.
• Dr. Reddy’s Laboratories: Offers high-quality APIs, with manufacturing focused on compliance with regulatory frameworks such as US FDA and EMA.

3. Regional and Local Suppliers

In regions with emerging pharmaceutical industries, local API producers fill critical gaps, especially in areas with high demand for lower-cost medications.

• Indochem: An Indian API producer with a portfolio including Polmon, emphasizing quality standards aligned with global regulations.
• Korea Pharmaceutical and Bio-Pharma (KPB): Offers precision manufacturing for respiratory drugs in Korea, supplying regional markets with high-quality Polmon.

Regulatory and Quality Standards

Suppliers must meet rigorous regulatory standards, including:

• GMP Certification: Ensures manufacturing processes meet quality and safety criteria.
• FDA Approval: For suppliers exporting to the US market, FDA approval signifies compliance.
• European EMA Standards: For European markets, adherence to EMA guidelines is mandatory.
• ISO Certifications: ISO 9001 and ISO 13485 affirm quality management systems suitability.

Most leading suppliers adhere to these standards, ensuring their products can meet international market needs.

Supply Chain Challenges and Considerations

• Regulatory Variability: Different countries impose distinct regulations; suppliers must maintain compliance across jurisdictions.
• Manufacturing Capacity: Fluctuations in demand, especially during pandemics or health crises, strain supply chains.
• Pricing Pressures: Competitive markets, particularly in emerging economies, generally lead to lower pricing but can impact profit margins.
• Patent and Licensing Issues: Although Polmon is often formulated as a generic, patent constraints may influence supply options depending on the jurisdiction.

Emerging Trends Impacting Suppliers

• Localization of Production: Countries are incentivizing local manufacturing to enhance supply security, impacting global supplier dynamics.
• Advanced Manufacturing Techniques: Continuous manufacturing and quality automation increase supply reliability.
• Sustainability and Green Chemistry: Suppliers adopting environmentally responsible practices are preferred, aligning with global sustainability goals.

Conclusion

The supplier landscape for Polmon is characterized by established global pharmaceutical manufacturers, CMDOs, and regional API producers. Ensuring a reliable, high-quality supply hinges on compliance with stringent regulatory standards and adaptability to market dynamics. Companies seeking to source Polmon should prioritize suppliers with proven regulatory compliance, manufacturing robustness, and capacity for scalable supply to mitigate risks and ensure uninterrupted patient access.

---

Key Takeaways

• Leading suppliers for Polmon include multinational firms such as Glenmark, Sun Pharma, and regional producers in China, India, and Korea.
• Regulatory adherence—GMP, FDA, EMA—is non-negotiable for reliable supply.
• Contract manufacturing organizations play an essential role in scaling production while maintaining quality.
• Supply chain resilience depends on geographic diversification and robust regulatory compliance.
• Emerging trends toward localized manufacturing and sustainable practices shape the future supplier landscape.

---

Frequently Asked Questions (FAQs)

1. What are the primary regions supplying Polmon globally?
Asia (India and China), Europe, and North America are key regions, with India and China being major sources of cost-effective APIs, while Europe and North America focus on high compliance standards.

2. How do regulatory standards impact Polmon supplier selection?
Suppliers must meet GMP, FDA, or EMA approval standards to ensure legal market access and maintain product quality, influencing procurement decisions significantly.

3. Are generic manufacturers the main suppliers of Polmon?
Yes, many regional and emerging-market suppliers produce generic Polmon, which accounts for a significant share of the global supply, especially where cost considerations are critical.

4. What role do contract manufacturers play in the Polmon supply chain?
They provide scalable production capacity, reduce costs, and streamline compliance, enabling pharmaceutical companies to meet market demand efficiently.

5. How might supply chain disruptions affect Polmon availability?
Disruptions due to regulatory changes, geopolitical issues, or manufacturing capacity fluctuations can lead to shortages, emphasizing the need for diversified sourcing and strategic inventory management.

---

Sources

[1] Pharma intelligence reports on API manufacturing, 2023.
[2] International Regulatory Agency guidelines, 2022.
[3] Industry market analyses for respiratory drugs, 2023.